Thomas Gottschalk announces overcoming of his cancer

As part of his treatment, Gottschalk underwent a total of 33 radiation treatments as well as two surgeries, according to Bild. He is currently not taking any medication, he said. „Medikamente nehme ich derzeit keine“, he is quoted as saying. In addition, the host is receiving a special vaccination against the cancer as part of a clinical study. He has already received eight of a total of twelve injections, Gottschalk explained. „Ich bekomme eine Impfung gegen den Krebs. Achtmal habe ich diese Spritze bereits bekommen. Zwölf sind es insgesamt“.

Treatment with radiation and vaccination

The vaccination is being tested as part of a research group at the children's clinic in Greifswald, in which Gottschalk is currently participating, according to his own statements. He receives an injection every 14 days, he said. „Im Abstand von 14 Tagen bekomme er eine Spritze“, the Bild-Zeitung quotes the host. At his last examination, no cancer cells were detected in his body anymore. „dass ich keinerlei Krebszellen mehr im Körper habe“, said Gottschalk.

In the future, the host must go for check-ups every three months, according to his own words. „Alle drei Monate müsse er nun zur Kontrolle“, he told the newspaper. Connected to this is the hope that the illness will remain permanently overcome. Gottschalk expressed confidence that he has now completed the therapy phase.

Check-ups every three months

The news of his recovery is likely to be received with great relief in the German entertainment industry. Gottschalk has been one of the country's most well-known television faces for decades, hosting shows including „Wetten, dass..?“ and appearing in numerous shows. After his last TV appearance in December 2024, he had largely withdrawn from public life. His cancer-free declaration is the host's first major health statement since the diagnosis became known.

Gottschalk did not comment on possible future television projects in the Bild report. The treating doctors are also not named in the report. The diagnosis of epithelioid angiosarcoma is considered rare; the disease occurs primarily in the skin, soft tissues, or internal organs and usually requires a combination of surgery, radiation, and drug therapy.

Research approach in Greifswald

The vaccination study at the Greifswald children's clinic, in which Gottschalk is participating, is part of a series of research approaches aimed at specifically alerting the immune system to tumor cells. Such therapeutic cancer vaccines are being tested internationally, but are still mostly in the clinical trial phase. Gottschalk had emphasized that he hopes to be able to contribute to research with his participation.

The Bild-Zeitung was the first to report on the recovery. Further independent confirmations of the host's statements were not initially available.